Present Serious, Not Common, Risks First, FDA Tells Watson In Letter On Gelnique
This article was originally published in The Pink Sheet Daily
Executive Summary
"Restroom stall cling" for the urinary incontinence drug used at medical meeting gets notice of violation letter from DDMAC.